Multidimensional Regulatory Network of YAP1 Driving Malignant Progression in Esophageal Cancer: Molecular Mechanisms and Targeted Therapy: A Review.
Saved in:
| Title: | Multidimensional Regulatory Network of YAP1 Driving Malignant Progression in Esophageal Cancer: Molecular Mechanisms and Targeted Therapy: A Review. |
|---|---|
| Authors: | Chen JH; The Second School of Clinical Medicine, Henan University of Traditional Chinese Medicine, Zhengzhou, China., Du SR; The Second School of Clinical Medicine, Henan University of Traditional Chinese Medicine, Zhengzhou, China., Liu C; The Second School of Clinical Medicine, Henan University of Traditional Chinese Medicine, Zhengzhou, China., Liu BB; The Second School of Clinical Medicine, Henan University of Traditional Chinese Medicine, Zhengzhou, China., Xu HY; Henan Provincial Research Center of Engineering Technology for Nuclear Protein Medical Detection, Zhengzhou Health College, Zhengzhou, China., Ji XY; Henan Provincial Research Center of Engineering Technology for Nuclear Protein Medical Detection, Zhengzhou Health College, Zhengzhou, China., Feng B; Department of Oncology, The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China., Ma CZ; Department of Oncology, The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China., Guo JH; Department of Oncology, The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China. |
| Source: | Oncology research [Oncol Res] 2026 Apr 22; Vol. 34 (5), pp. 11. Date of Electronic Publication: 2026 Apr 22 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Tech Science Press Country of Publication: United States NLM ID: 9208097 Publication Model: eCollection Cited Medium: Internet ISSN: 1555-3906 (Electronic) Linking ISSN: 09650407 NLM ISO Abbreviation: Oncol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
